Business
Press Release Dec 01 2025
Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release US FDA Accepts Wockhardt s New Drug Application for Breakthrough Antibiotic Zaynich .
About this update from Wockhardt Limited
[{"type":"text","content":" Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release US FDA Accepts Wockhardt s New Drug Application for Breakthrough Antibiotic Zaynich . View Attachment","length":331,"tagName":"div"}]